![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. 200575-15-1
2. 1h-pyrazole-5-carboxamide, 4-[[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoyl]amino]-1-methyl-3-propyl-
3. 4-[[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylbenzoyl]amino]-2-methyl-5-propylpyrazole-3-carboxamide
4. 4-[[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoyl]amino]-1-methyl-3-propyl-1h-pyrazole-5-carboxamide
5. 4-{{2-ethoxy-5-[(4-methyl-1-piperazinyl)-sulfonyl]-benzoyl}-amino}-1-methyl-3-propyl-1h-pyrazole-5-carboxamide
6. Sildenafil Impurity 22
7. Schembl4565717
8. Dtxsid70451969
9. Bcp34322
10. Zinc21992760
11. Akos015963189
12. Ac-20141
13. Db-050324
14. Ft-0617331
15. A814208
16. 1-methyl-3-propyl-4-[2-ethoxy-5-(4-methylpiperazinosulfonyl)phenylcarbonylamino]-1h-pyrazole-5-carboxamide
Molecular Weight | 492.6 g/mol |
---|---|
Molecular Formula | C22H32N6O5S |
XLogP3 | 1.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 9 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 148 |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 813 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |